Patent ID: 9382588
Filing Date: 2016-07-05
CPC Classification: C07K,C12Q,G01N

Claim Text:
1. A kit for determining outcome of a patient with breast cancer comprising (a) at least one PBX1 oligonucleotide selected from the group of SEQ ID NO:1 and SEQ ID NO:2; and (b) a detection mechanism for one or more genes selected from the group of AURKA, AURKB, BUB1, CCNB1, CDCA3, CDKN3, CEP55, DLGAP5, FEN1, FOXM1, KIF20A, MAD2L1, MELK, MLF1IP, NUSAP1, PRC1, RACGAP1, RAD54L, RFC4, RRM2, TACC3, TOP2A, TROAP and UBE2C.